“Analysis of the association between CFH Y402H polymorphism and response to intravitreal ranibizumab in patients with neovascular age-related macular degeneration (nAMD)” (2018) Biomolecules and Biomedicine, 18(3), pp. 260–267. doi:10.17305/bjbms.2018.2493.